Oncogenic Role of ADAM32 in Hepatoblastoma: A Potential Molecular Target for Therapy

SIMPLE SUMMARY: Hepatoblastoma (HBL) is a rare hepatic malignancy occurring mainly in early childhood. Although recently developed treatment regimens have improved prognosis, many refractory cases still exist, and the anticancer drug cis-diamminedichloroplatinum—cisplatin—primarily used in HBL treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukazawa, Takahiro, Tanimoto, Keiji, Yamaoka, Emi, Kojima, Masato, Kanawa, Masami, Hirohashi, Nobuyuki, Hiyama, Eiso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562177/
https://www.ncbi.nlm.nih.gov/pubmed/36230656
http://dx.doi.org/10.3390/cancers14194732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562177/
https://www.ncbi.nlm.nih.gov/pubmed/36230656
http://dx.doi.org/10.3390/cancers14194732

Ejemplares similares